Previous Close | 18.53 |
Open | 19.07 |
Bid | 17.77 x 100 |
Ask | 17.88 x 200 |
Day's Range | 17.43 - 19.24 |
52 Week Range | 10.38 - 20.67 |
Volume | |
Avg. Volume | 132,255 |
Market Cap | 937.552M |
Beta (5Y Monthly) | 1.12 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Recent Financial Highlights Indicate Strong Cash Position and Advancements in Clinical Studies
Tyra Biosciences Inc (NASDAQ:TYRA), a company focused on developing precision medicine for patients with cancer, has reported an insider sell according to a recent SEC filing.
Tyra Biosciences Inc (NASDAQ:TYRA), a biotechnology company focused on developing precision medicines targeting oncogenic drivers of cancer, has reported an insider sell according to the latest SEC filings.